Impact of C-MYC/BCL2 Double Expression on Survival Outcomes After Autologous Transplantation in Relapsed/Refractory Diffuse Large B Cell Lymphoma-A Nationwide Retrospective Analysis in Singapore.
Saved in:
| Title: | Impact of C-MYC/BCL2 Double Expression on Survival Outcomes After Autologous Transplantation in Relapsed/Refractory Diffuse Large B Cell Lymphoma-A Nationwide Retrospective Analysis in Singapore. |
|---|---|
| Authors: | Tan JY; Department of Hematology, Singapore General Hospital, Singapore, Singapore.; National Cancer Centre Singapore, Singapore, Singapore., Ling VWT; Department of Hematology-Oncology, National University Cancer Institute, Singapore, Singapore., Ng LCK; Department of Hematology, Singapore General Hospital, Singapore, Singapore.; National Cancer Centre Singapore, Singapore, Singapore., Krisnadi C; Department of Hematology, Singapore General Hospital, Singapore, Singapore.; National Cancer Centre Singapore, Singapore, Singapore., Tan MSY; Department of Hematology, Singapore General Hospital, Singapore, Singapore.; National Cancer Centre Singapore, Singapore, Singapore., Grigoropoulos NF; Department of Hematology, Singapore General Hospital, Singapore, Singapore.; National Cancer Centre Singapore, Singapore, Singapore., Ong SY; Department of Hematology, Singapore General Hospital, Singapore, Singapore.; National Cancer Centre Singapore, Singapore, Singapore., Nagarajan C; Department of Hematology, Singapore General Hospital, Singapore, Singapore.; National Cancer Centre Singapore, Singapore, Singapore., Quek JKS; Department of Hematology, Singapore General Hospital, Singapore, Singapore.; National Cancer Centre Singapore, Singapore, Singapore., Than H; Department of Hematology, Singapore General Hospital, Singapore, Singapore.; National Cancer Centre Singapore, Singapore, Singapore., Lee J; Department of Hematology-Oncology, National University Cancer Institute, Singapore, Singapore., Chan E; Department of Hematology-Oncology, National University Cancer Institute, Singapore, Singapore., Tan LK; Department of Hematology-Oncology, National University Cancer Institute, Singapore, Singapore., Hwang WYK; Department of Hematology, Singapore General Hospital, Singapore, Singapore.; National Cancer Centre Singapore, Singapore, Singapore., Goh YT; Department of Hematology, Singapore General Hospital, Singapore, Singapore.; National Cancer Centre Singapore, Singapore, Singapore., Linn YC; Department of Hematology, Singapore General Hospital, Singapore, Singapore.; National Cancer Centre Singapore, Singapore, Singapore., Koh LP; Department of Hematology-Oncology, National University Cancer Institute, Singapore, Singapore., Ho AYL; Department of Hematology, Singapore General Hospital, Singapore, Singapore.; National Cancer Centre Singapore, Singapore, Singapore., Lim FWI; Department of Hematology, Singapore General Hospital, Singapore, Singapore.; National Cancer Centre Singapore, Singapore, Singapore., Poon ML; Department of Hematology-Oncology, National University Cancer Institute, Singapore, Singapore., Chen Y; Department of Hematology, Singapore General Hospital, Singapore, Singapore.; National Cancer Centre Singapore, Singapore, Singapore. |
| Source: | Hematological oncology [Hematol Oncol] 2025 Jan; Vol. 43 (1), pp. e70030. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8307268 Publication Model: Print Cited Medium: Internet ISSN: 1099-1069 (Electronic) Linking ISSN: 02780232 NLM ISO Abbreviation: Hematol Oncol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1099-1069 |
|---|---|
| DOI: | 10.1002/hon.70030 |
